Zahra Hoseini Tavassol

Dr. Zahra Hoseini Tavassol

Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Tehrān, Iran
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SSSalman Shirvani-Rad
Salman Shirvani-Rad
OTOzra Tabatabaei-Malazy
Ozra Tabatabaei-Malazy
SMShahrzad Mohseni
Shahrzad Mohseni
SHShirin Hasani-Ranjbar
Shirin Hasani-Ranjbar
ASAhmad-Reza Soroush
Ahmad-Reza Soroush
BLBagher Larijani
Bagher Larijani
Background. Considering the observed role of probiotics in modulating gut microbiome, probiotics are discussed to be one potential complementary therapy for obesity management in recent years. The aim of the present study was to systematically review the meta-analyses of controlled trials and investigate the effects of probiotics on obesity. Methods. A comprehensive search was conducted on PubMed, Web of Science, and Cochrane Library web databases up to May 2020. Inclusion criteria were meta-analyses of controlled trials which evaluated the impact of probiotics on obesity in English language. Meta-analyses done on pregnant women, children, animal studies, or the effect of prebiotics on anthropometric indices were excluded. Results. Within 325 recorded studies, 20 studies met the inclusion criteria consisting of 16676 overweight/obese adults with different underlying disorders such as nonalcoholic fatty liver disease (NAFLD), or polycystic ovary syndrome (PCOS). The length of intervention varied from 2 to 26 weeks. Results of meta-analyses have shown a moderate effect of probiotics on body weight in overweight/obese adults: from 0.526kg/m2 (95 CI: 0.810, 0.247) to 0.25kg/m2 (95 CI: 0.33, 0.17). Body mass index (BMI) was changed from 1.46kg/m2 (95 CI: 2.44, 0.48) to 1.08kg/m2 (95 CI: 2.05, 0.11) in NAFLD. Probiotics could reduce BMI from 0.36kg/m2 (95 CI: 0.74, 0.02) to 0.29kg/m2 (95 CI: 0.54, 0.03) in patients with PCOS. Conclusion. It seems that the probiotic products could have beneficial effects as an adjunct therapy for care and management of obesity when used in high dose. However, due to heterogeneity of included studies, it is required to confirm our results by more meta-analyses of clinical trials.

23 January 2021 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
SRShahrbanoo Keshavarz Azizi Raftar
Shahrbanoo Keshavarz Azizi Raftar
ZTZahra Hoseini Tavassol
Zahra Hoseini Tavassol
MAMeysam Amiri
Meysam Amiri
HEHanieh-Sadat Ejtahed
Hanieh-Sadat Ejtahed
MZMehrangiz Zangeneh
Mehrangiz Zangeneh
SSSeyed Davar Siadat
Seyed Davar Siadat

18 April 2020 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
HEHanieh-Sadat Ejtahed
Hanieh-Sadat Ejtahed
EAEdris Ardeshirlarijani
Edris Ardeshirlarijani
OTOzra Tabatabaei-Malazy
Ozra Tabatabaei-Malazy
ZTZahra Hoseini Tavassol
Zahra Hoseini Tavassol
SHShirin Hasani-Ranjbar
Shirin Hasani-Ranjbar
BLBagher Larijani
Bagher Larijani

1 April 2023 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
ZTZahra Hoseini Tavassol
Zahra Hoseini Tavassol
HEHanieh-Sadat Ejtahed
Hanieh-Sadat Ejtahed
BLBagher Larijani
Bagher Larijani
SHShirin Hasani-Ranjbar
Shirin Hasani-Ranjbar
Background: Trimethylamine N-Oxide (TMAO), as a gut microbiota-derived metabolite, has been associated with a number of chronic diseases like cardiovascular diseases. Objective: Considering the increasing prevalence of non-communicable diseases (NCDs), we conducted a comprehensive overview to discuss the TMAO association with NCDs. Methods: A comprehensive search has been conducted on PubMed, Web of Science, and Scopus databases up to December, 2020. The inclusion criteria were all related observational studies that surveyed the association between TMAO levels and non-communicable diseases. Interventional studies, animal experiments, reviews, case reports, letters, congress abstracts, and studies that were not published in English were excluded. Moreover, related review studies were separately discussed. Results: Within 2191 recorded studies, 99 cross-sectional, case-control and cohort studies met the inclusion criteria. The most common diseases associated with TMAO levels are cardiovascular diseases, diabetes, kidney disease, stroke, inflammatory diseases, neurological disorders, and cancer. Elevated TMAO levels as a consequence of alteration in gut microbiota composition and dietary intake can lead to the incidence of NCDs. The high levels of TMAO can disrupt the homeostasis of glucose and lipids and induce inflammation that leads to serious NCDs. Conclusion: There is a dose-response relationship between TMAO levels and NCDs progression. Therefore, it can be studied as a therapeutic target or prognostic biomarker for dealing with NCDs.

30 January 2022 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
ZTZahra Hoseini Tavassol
Zahra Hoseini Tavassol
ZSZahra Sajjadpour
Zahra Sajjadpour
SHShirin Hasani-Ranjbar
Shirin Hasani-Ranjbar
MSMahnaz Pejman Sani
Mahnaz Pejman Sani
HMHamidreza Aghaei Meybodi
Hamidreza Aghaei Meybodi
BLBagher Larijani
Bagher Larijani
Purpose Diabetic foot ulcer is a public health concern around the world. These wounds are prone to a variety of infections including Clostridium Tetani that may lead to tetanus. The aim of this study was to evaluate the immunity status as a result of tetanus vaccination and other preventive measures in these patients. Methods We conducted a narrative review of previous studies which were related to the risk of tetanus infection in diabetic foot patients by searching electronic databases. Results It was found that usually tetanus antibody titers in diabetic patients are below the protective level and they are not appropriately vaccinated. Therefore, diabetes and lack of immunity, put diabetic foot ulcer patients more at risk of tetanus. But this problem is not given serious attention in diabetes care. Conclusions Thus, it is recommended to provide specific guidelines for tetanus vaccination and prophylaxis in diabetic patients. These recommendations can play a vital role in the prevention of diabetic foot ulcers complication.

1 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
KKKazem Khalagi
Kazem Khalagi
ZTZahra Hoseini Tavassol
Zahra Hoseini Tavassol
HEHanieh-Sadat Ejtahed
Hanieh-Sadat Ejtahed
GSGita Shafiee
Gita Shafiee
FRFarideh Razi
Farideh Razi
INIraj Nabipour
Iraj Nabipour
Objectives The Bushehr Elderly Health (BEH) Program is a population-based prospective cohort study, designed to address the increasing health challenges associated with an aging population. The third phase of BEH program was carried out with aim to repeat the measurements about the state of non-communicable diseases (NCDs), particularly cardiovascular and musculoskeletal diseases, and cognitive function, and their determinants and consequences in the older adults. This article presents the profile of the third phase measurements of BEH program. Methods Phase III of the BEH Program was conducted six years after the second phase (stage), involving repeated measurements among participants aged 60 and above residing in Bushehr city. Previous phase participants were invited to take part in this phase. This phase was a repeat of the measurements conducted in the previous phases implicated comprehensive questionnaires, physical and anthropometric examinations, whole body and bone density scan, diagnostic laboratory tests, and biobanking of biological samples included serum, EDP, stool, and saliva. Results The successful assessment has been completed for a representative sample of older adults, with an extensive data for future analysis. In this phase of BEH program, a total of 1,345 participants were enrolled in the study, a response rate of 64.7%. The mean (standard deviation) age was 74.3 (4.6) years and 50.4% of the participants were males. Conclusion The BEH program’s repeated measures provide valuable insights into how health-related variables among participants change over time, as well as the needs of older Iranian adults. Also, adding stool and saliva samples to the BEH program biobank allows for expanded microbiota evaluation in this study. This study results inform public health policy to address the growing burden of NCDs among older adults and will guide clinicians, policymakers, and health managers in developing effective strategies to promote health outcomes and quality of life of older adults.